) EZViable? Calcein AM Cell Viability Assay Kit (Fluorometric) |
|||
| K305-1000 | Biovision | EUR 359 | |
 Activity Assay Kit (Colorimetric)) Carbonic Anhydrase (CA) Activity Assay Kit (Colorimetric) |
|||
| K472-100 | Biovision | EUR 550 | |
 AM-679 |
|||
| B2521-1 | Biovision | EUR 153 | |
AM-679 |
|||
| B2521-5 | Biovision | EUR 430 | |
 AM 281 |
|||
| B6603-10 | ApexBio | 10 mg | EUR 195 |
|
Description: AM 281 is a potent and selective antagonist/inverse agonist of CB1 cannabinoid receptor with Ki values of 12 and 4200 nM for CB1 and CB2 receptors, respectively [1].CB1 cannabinoid receptor is a G protein-coupled receptor and is mainly expressed in the brain. |
|||
AM 281 |
|||
| B6603-5 | ApexBio | 5 mg | EUR 125 |
|
Description: AM 281 is a potent and selective antagonist/inverse agonist of CB1 cannabinoid receptor with Ki values of 12 and 4200 nM for CB1 and CB2 receptors, respectively [1].CB1 cannabinoid receptor is a G protein-coupled receptor and is mainly expressed in the brain. |
|||
AM 281 |
|||
| B6603-50 | ApexBio | 50 mg | EUR 635 |
|
Description: AM 281 is a potent and selective antagonist/inverse agonist of CB1 cannabinoid receptor with Ki values of 12 and 4200 nM for CB1 and CB2 receptors, respectively [1].CB1 cannabinoid receptor is a G protein-coupled receptor and is mainly expressed in the brain. |
|||
 AM 404 |
|||
| B6604-100 | ApexBio | 100 mg | EUR 419 |
|
Description: AM 404 is a selective inhibitor of anandamide transport [1]. Also, it is an agonist of CB1 cannabinoid receptor and potential vanilloid type 1 (TRPV1). |
|||
AM 404 |
|||
| B6604-50 | ApexBio | 50 mg | EUR 261 |
|
Description: AM 404 is a selective inhibitor of anandamide transport [1]. Also, it is an agonist of CB1 cannabinoid receptor and potential vanilloid type 1 (TRPV1). |
|||
 BAPTA-AM |
|||
| B4758-10 | ApexBio | 10 mg | EUR 128 |
|
Description: BAPTA-AM is a selective calcium chelator [1]. Ca2+ is one of the most ubiquitous and versatile intracellular signaling molecules that control numerous cellular processes such as neurotransmitter release, contraction of all muscle cell types and fertilization [4]. |
|||
BAPTA-AM |
|||
| B4758-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 142 |
|
Description: BAPTA-AM is a selective calcium chelator [1]. Ca2+ is one of the most ubiquitous and versatile intracellular signaling molecules that control numerous cellular processes such as neurotransmitter release, contraction of all muscle cell types and fertilization [4]. |
|||
BAPTA-AM |
|||
| B4758-50 | ApexBio | 50 mg | EUR 325 |
|
Description: BAPTA-AM is a selective calcium chelator [1]. Ca2+ is one of the most ubiquitous and versatile intracellular signaling molecules that control numerous cellular processes such as neurotransmitter release, contraction of all muscle cell types and fertilization [4]. |
|||
 BCECF-AM |
|||
| B5370-1 | ApexBio | 1 mg | EUR 160 |
BCECF-AM |
|||
| B5370-25 | ApexBio | 25 mg | EUR 2111 |
BCECF-AM |
|||
| B5370-5 | ApexBio | 5 mg | EUR 545 |
 AM 1172 |
|||
| B7392-10 | ApexBio | 10 mg | EUR 235 |
|
Description: AM 1172 is a potent and selective inhibitor of stable anandamide uptake with IC50 of 2.43102.5 ?M and fatty acid amide hydrolase (FAAH) with Ki of 3.18 ?M. FAAH, is an integral membrane hydrolase that hydrolyzes bioactive amides. |
|||
AM 1172 |
|||
| B7392-100 | ApexBio | 100 mg | EUR 1414 |
|
Description: AM 1172 is a potent and selective inhibitor of stable anandamide uptake with IC50 of 2.43102.5 ?M and fatty acid amide hydrolase (FAAH) with Ki of 3.18 ?M. FAAH, is an integral membrane hydrolase that hydrolyzes bioactive amides. |
|||
AM 1172 |
|||
| B7392-5 | ApexBio | 5 mg | EUR 147 |
|
Description: AM 1172 is a potent and selective inhibitor of stable anandamide uptake with IC50 of 2.43102.5 ?M and fatty acid amide hydrolase (FAAH) with Ki of 3.18 ?M. FAAH, is an integral membrane hydrolase that hydrolyzes bioactive amides. |
|||
AM 1172 |
|||
| B7392-50 | ApexBio | 50 mg | EUR 830 |
|
Description: AM 1172 is a potent and selective inhibitor of stable anandamide uptake with IC50 of 2.43102.5 ?M and fatty acid amide hydrolase (FAAH) with Ki of 3.18 ?M. FAAH, is an integral membrane hydrolase that hydrolyzes bioactive amides. |
|||
 AM-2394 |
|||
| HY-100221 | MedChemExpress | 10mM/1mL | EUR 216 |
BAPTA-AM |
|||
| HY-100545 | MedChemExpress | 50mg | EUR 436 |
 AM-2099 |
|||
| HY-100727 | MedChemExpress | 10mM/1mL | EUR 361 |
BCECF-AM |
|||
| HY-101883 | MedChemExpress | 1mg | EUR 316 |
 AM-0902 |
|||
| HY-108329 | MedChemExpress | 100mg | EUR 1153 |
 RT-AM |
|||
| HY-108715A | MedChemExpress | 1mg | EUR 452 |
 Calcein-AM |
|||
| HY-D0041 | MedChemExpress | 100ug | EUR 147 |
 EGTA-AM |
|||
| HY-D0973 | MedChemExpress | 5mg | EUR 587 |
 AM-4668 |
|||
| HY-12585 | MedChemExpress | 5mg | EUR 371 |
 AM-1638 |
|||
| HY-13467 | MedChemExpress | 5mg | EUR 452 |
 AM 103 |
|||
| HY-14163 | MedChemExpress | 1mg | EUR 2254 |
Calcein-AM |
|||
| GT0291-1MG | Glentham Life Sciences | 1 mg | EUR 341 |
 SBFI-AM |
|||
| GK8201-1MG | Glentham Life Sciences | 1 mg | EUR 628 |
 AM resin |
|||
| 20-abx095149 | Abbexa |
|
|
|
|||
 AM-095 |
|||
| 9581-25 | Biovision | EUR 588 | |
AM-095 |
|||
| 9581-5 | Biovision | EUR 185 | |
 AM 114 |
|||
| A8163-10 | ApexBio | 10 mg | EUR 119 |
|
Description: AM 114, a derivative of boronic chalcone, is a potent small-molecule inhibitor of the proteasome that inhibits the chymotrypsin-like activity of the 20S proteasome, with a value of 50% inhibition concentration IC50 of approximately 1 ?M |
|||
AM 114 |
|||
| A8163-25 | ApexBio | 25 mg | EUR 189 |
|
Description: AM 114, a derivative of boronic chalcone, is a potent small-molecule inhibitor of the proteasome that inhibits the chymotrypsin-like activity of the 20S proteasome, with a value of 50% inhibition concentration IC50 of approximately 1 ?M |
|||
AM 114 |
|||
| A8163-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 108 |
|
Description: AM 114, a derivative of boronic chalcone, is a potent small-molecule inhibitor of the proteasome that inhibits the chymotrypsin-like activity of the 20S proteasome, with a value of 50% inhibition concentration IC50 of approximately 1 ?M |
|||
AM 114 |
|||
| A8163-50 | ApexBio | 50 mg | EUR 282 |
|
Description: AM 114, a derivative of boronic chalcone, is a potent small-molecule inhibitor of the proteasome that inhibits the chymotrypsin-like activity of the 20S proteasome, with a value of 50% inhibition concentration IC50 of approximately 1 ?M |
|||
AM 114 |
|||
| A8163-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: AM 114, a derivative of boronic chalcone, is a potent small-molecule inhibitor of the proteasome that inhibits the chymotrypsin-like activity of the 20S proteasome, with a value of 50% inhibition concentration IC50 of approximately 1 ?M |
|||
 Calcein AM |
|||
| 1755-1000 | Biovision | EUR 370 | |
Calcein AM |
|||
| 1755-250 | Biovision | EUR 327 | |
Calcein AM |
|||
| 1755-50 | Biovision | EUR 131 | |
 NAADP-AM |
|||
| 21000 | AAT Bioquest | 1 mg | EUR 876 |
|
|||
 BCECF, AM |
|||
| 21202 | AAT Bioquest | 1 mg | EUR 176 |
|
|||
 BAPTA AM |
|||
| 2242-25 | Biovision | EUR 262 | |
BAPTA AM |
|||
| 2242-5 | Biovision | EUR 109 | |
 cAMP AM |
|||
| 20300 | AAT Bioquest | 1 mg | EUR 50 |
|
|||
NAADP-AM |
|||
| 20997 | AAT Bioquest | 2X50 ug | EUR 306 |
|
|||
NAADP-AM |
|||
| 20998 | AAT Bioquest | 250 ug | EUR 393 |
|
|||
 AM-251 |
|||
| B2718-25 | Biovision | 25 mg | EUR 510 |
AM-251 |
|||
| B2718-5 | Biovision | 5 mg | EUR 166 |
 AM-92016 Hydrochloride |
|||
| B2569-25 | Biovision | EUR 631 | |
AM-92016 Hydrochloride |
|||
| B2569-5 | Biovision | EUR 196 | |
 AM 92016 hydrochloride |
|||
| B6482-10 | ApexBio | 10 mg | EUR 318 |
|
Description: AM 92016 hydrochloride is a specific inhibitor of delayed rectifier potassium current [1]. Potassium channel is an ion channel and acts to reset the resting potential and shapes the action potential. |
|||
 AM-095 Sodium |
|||
| B1225-25 | Biovision | EUR 631 | |
) AM-92016 (hydrochloride) |
|||
| HY-101253 | MedChemExpress | 10mM/1mL | EUR 176 |
 Fluo-4 AM |
|||
| HY-101896 | MedChemExpress | 100ug | EUR 546 |
 Fura-2 AM |
|||
| HY-101897 | MedChemExpress | 1mg | EUR 408 |
 Indo-1 AM |
|||
| HY-101898 | MedChemExpress | 1mg | EUR 366 |
 Rhod-2 AM |
|||
| HY-D0989 | MedChemExpress | 1mg | EUR 436 |
 Fura 2-AM |
|||
| GK3824-1MG | Glentham Life Sciences | 1 mg | EUR 269 |
 FURA-4F/AM |
|||
| 9550-50 | Biovision | EUR 131 | |
FURA-4F/AM |
|||
| 9550-set | Biovision | EUR 349 | |
 FURA-5F/AM |
|||
| 9551-50 | Biovision | EUR 137 | |
FURA-5F/AM |
|||
| 9551-set | Biovision | EUR 398 | |
) Calcein AM, (20x50ug) |
|||
| 80011-3 | Biotium | 20ST | EUR 242 |
|
Description: Minimum order quantity: 1 unit of 20ST |
|||
 BAPTA, AM ester |
|||
| 50000 | Biotium | 25MG | EUR 205 |
|
Description: Minimum order quantity: 1 unit of 25MG |
|||
BAPTA, AM ester |
|||
| 50000-1 | Biotium | 20MG | EUR 243 |
|
Description: Minimum order quantity: 1 unit of 20MG |
|||
 BCECF, AM ester |
|||
| 51012 | Biotium | 1MG | EUR 137 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
 Rhod-FF, AM |
|||
| 21077 | AAT Bioquest | 1 mg | EUR 306 |
|
|||
Rhod-FF, AM |
|||
| 21078 | AAT Bioquest | 10x50 ug | EUR 219 |
|
|||
 FURA-2 Am |
|||
| 2243-1 | Biovision | EUR 262 | |
FURA-2 Am |
|||
| 2243-set | Biovision | EUR 153 | |
 Fluo-2, AM |
|||
| 20494 | AAT Bioquest | 10x50 ug | EUR 176 |
|
|||
Fluo-2, AM |
|||
| 20495 | AAT Bioquest | 1 mg | EUR 219 |
|
|||
 Poricoic acid AM |
|||
| TBW00284 | ChemNorm | 10mg | EUR 1295 |
 CA/ Rat CA ELISA Kit |
|||
| ELA-E0875r | Lifescience Market | 96 Tests | EUR 886 |
 AN3 CA |
|||
| C0026002 | Addexbio | One Frozen vial | EUR 543 |
 CA-074 |
|||
| HY-103350 | MedChemExpress | 10mg | EUR 587 |
 CA-5f |
|||
| HY-112698 | MedChemExpress | 5mg | EUR 176 |
 CA 074 |
|||
| A1926-1 | ApexBio | 1 mg | EUR 148 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-10 | ApexBio | 10 mg | EUR 485 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-25 | ApexBio | 25 mg | EUR 746 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-5 | ApexBio | 5 mg | EUR 311 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 432 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
 CA-1001 |
|||
| B2669-25 | Biovision | 25mg | EUR 591 |
CA-1001 |
|||
| B2669-5 | Biovision | 5mg | EUR 186 |
CA-074 |
|||
| B2971-1 | Biovision | 1 mg | EUR 196 |